Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3723810016 | Mogamulizumab (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3723811017 | Mogamulizumab | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 1169251000172117 | mogamulizumab | fr | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | Belgian module (core metadata concept) |
| 1199961000172112 | mogamulizumab | nl | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | Belgian module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Mogamulizumab (substance) | Is a | Chemokine receptor antagonist | true | Inferred relationship | Some | ||
| Mogamulizumab (substance) | Has disposition (attribute) | Antiviral (disposition) | false | Inferred relationship | Some | ||
| Mogamulizumab (substance) | Is a | Monoclonal antibody | true | Inferred relationship | Some | ||
| Mogamulizumab (substance) | Has disposition (attribute) | Chemokine receptor antagonist (disposition) | true | Inferred relationship | Some | ||
| Mogamulizumab (substance) | Is a | Antineoplastic agent (substance) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing mogamulizumab (medicinal product) | Has active ingredient | True | Mogamulizumab (substance) | Inferred relationship | Some | 1 |
| Mogamulizumab-containing product in parenteral dose form | Has active ingredient | True | Mogamulizumab (substance) | Inferred relationship | Some | 1 |
| Mogamulizumab only product | Has active ingredient | True | Mogamulizumab (substance) | Inferred relationship | Some | 1 |
| Product containing only mogamulizumab in parenteral dose form (medicinal product form) | Has active ingredient | True | Mogamulizumab (substance) | Inferred relationship | Some | 1 |
Reference Sets
Belgian subset for AllergyIntolerance, causative agent, drug
FHIR